Industrial metals continue momentum as investors cheer another better-than-expected inflation report in the US
The unskilled workforce in particular will be affected by the steps the country will be compelled to take
Some of the employees of the arms manufacturer have not been paid for more than two years
The premier announced her cabinet after a meeting with the ANC’s deployment committee and its alliance partners
The Walt Disney business bets on ad-free viewing as it hikes premiums
Stats SA says ongoing power cuts limited recovery in the sector and reduced production volumes
The improved sentiment is a result of increased merchandise export and import volumes and more new vehicles sold, Sacci report says
Producer price index fell 0.5% in July from a month earlier, largely reflecting a drop in energy costs
Top swimmers have a rivalry that could develop into one of SA sport’s greatestt
The Italian SUV outguns the Bentley Bentayga's record
Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed US law could change that, bringing the ledger system to the pharmaceutical business.
The Drug Supply Chain Security Act from 2013 requires drug companies and their supply-chain partners to more closely track where their finished products are shipped, making counterfeit medicines harder to sneak into the system and easing drug recalls.
By 2020, pharmacies and hospitals must be able to verify that the drugs they are dispensing came from manufacturers or repackagers, which divvy up huge batches of pharmaceuticals into the actual bottles that get distributed in pharmacies or hospitals. While pharma giants are still evaluating how to comply, healthcare analysts say the impending deadline is leading firms to seriously consider the blockchain, since it is designed to create detailed and immutable databases.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email firstname.lastname@example.org or call 0860 52 52 00. Got a subscription voucher? Redeem it now
Would you like to comment on this article? Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.